updated Sun. March 31, 2024
-
Anderson Valley
February 8, 2018
The price diabetics pay for Eli Lilly's insulin drugs Humalog and Humulin have both risen some 225% since 2011. Eli Lilly also has several blockbuster drugs including the erectile dysfunction drug Cialis (Surely you've seen their TV commercial where a couple tenderly holds hands across side-by-sideÃÂ ...
Union of Concerned Scientists (blog)
February 6, 2018
In July, the Indianapolis Business Journal reported that in the last 20 years, while the price of milk went up 23 percent, the cost of a Dodge minivan rose 21 percent and general inflation was 32 percent, the price of Lilly's insulin drugs Humalog and Humulin skyrocketed by 1,157 percent and nearly 800ÃÂ ...
Market Realist
January 30, 2018
Eli Lilly & Co.'s (LLY) Human Pharmaceuticals segment includes products from therapeutic areas including endocrine products, neuroscience products, oncology products, and cardiovascular products. The Human Pharmaceuticals business is expected to report growth in revenues, driven by strong salesÃÂ ...
Market Realist
January 30, 2018
This growth was also due to higher realized prices of Humulin, Cialis, and Forteo. However, lower sales from Strattera, Cymbalta, Humalog, and Alimta are expected to partially offset this growth during 4Q17. The overall contribution of the Human Pharmaceuticals segment is expected to comprise ~87.0% ofÃÂ ...
Market Realist
January 30, 2018
Eli Lilly & Co.'s (LLY) Human Pharmaceuticals segment includes products from therapeutic areas including endocrine products, neuroscience products, oncology products, and cardiovascular products. The Human Pharmaceuticals business is expected to report growth in revenues, driven by strong salesÃÂ ...
Moneyshow.com
January 29, 2018
Five of its blockbusters – annual sales of $1 billion or more – are mature drugs: Humalog, Alimta (lung cancer), Forteo (osteoporosis), Humulin (synthesized insulin), and Cialis (erectile dysfunction). Lilly sales dipped a few years back after its star drug, antidepressant Cymbalta, lost exclusivity. But althoughÃÂ ...
RevCycleIntelligence.com
January 24, 2018
Azar served as a top executive at the pharmaceutical company, Eli Lilly, for about a decade. The global company manufactures brand-name drugs, such as Cialis, Humulin, and Trulicity. Azar resigned from the company in January 2017. Using his experience as big pharma executive, Azar expects to lowerÃÂ ...
Electronics360
January 15, 2018
In 1982, the first insulin using rDNA technology, Humulin R and N, were marketed. Previously, insulin for human use was produced from animal pancreas -- a complex process that could not always meet demand. At the time, Dr. Henry Miller, the medical officer in charge of Humulin at the Food and DrugÃÂ ...
Fremont Tribune
January 11, 2018
Citing data from Bernstein Research, CNBC recently said that the prices of Lilly's insulin drugs Humalog and Humulin N rose 20.81% in 2014 and 16.96% in 2015, under Azar's watch. Sen. Bernie Sanders, I-Vermont, has accused Lilly -- along with Novo Nordisk and Sanofi, which also sell insulin productsÃÂ ...
Market Realist
July 28, 2017
Eli Lilly in 2Q17: Humulin and Endocrine Products ... Humulin and Forteo reported growth in 2Q17 revenues, while Humalog reported lower sales. Humulin. The Humulin portfolio includes concentrated insulin products used to lower blood sugar levels in patients with Type 1 and Type 2 diabetes mellitus,ÃÂ ...
Pharmacy Times
July 24, 2017
The most common adverse effect reported with Humulin R U-500 is hypoglycemia. Studies show that patients are at risk for severe hypoglycemia as long as 18-24 hours post injection and should always be considered a risk factor if the patient is found unresponsive. For this reason patients should also beÃÂ ...
Diabetes In Control
January 22, 2016
For the first time Humulin % U-500 will now be available in a pen. This will help to prevent all the errors that this insulin has had in the past because of the confusion with units and cc's. The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's Humulinî R U-500 KwikPenîà...
Pulse
December 6, 2017
... basal secretion while oral hypoglycaemic medications can be continued. In type 2 diabetes metformin should be continued provided there are no contraindications. NICE recommends starting with NPH (neutral protamine hagedorn), also known as isophane insulin, such as Humulin I or Human Insulatard ...
ModernHealthcare.com
November 29, 2017
Azar's nomination raised skeptics' concerns that he would be pharma-friendly since he has just stepped down as president of the U.S. branch of Eli Lilly & Co. During his tenure, Lilly's prices for insulin drugs Humalog and Humulin have spiked about 225% since 2011. Azar's tenure ran from 2012 to 2017.
Nasdaq
November 22, 2017
Lilly has a strong portfolio of diabetes treatments including Trulicity (GLP-1), Jardiance (SGLT-2), Trajenta, Humulin, Basaglar, Humalog, and Glyxambi. Also, it has a diabetes alliance with Boehringer Ingelheim for many of these products. The company is seeking label expansion of some of these drugs.
HealthExec
November 21, 2017
According to CNBC, the price of its insulin drugs Humalog and Humulin N rose nearly 21 percent in 2014 and 17 percent in 2015. Azar's pharmaceutical ties have led one member of the Senate health committee, Sen. Bernie Sanders, I-Vermont, to preemptively announce that he would “vigorously opposeÃÂ ...
The Center for Biosimilars
November 21, 2017
... of Columbia, alleges that drug maker Eli Lilly illegally worked with Healthstar Communications and VMS Biomarketing to provide free nursing services to induce healthcare providers to prescribe the drug maker's insulin products Humalog and Humulin (as well as the company's osteoporosis drug Forteo).
Medical Marketing and Media
November 17, 2017
Eli Lilly settled a lawsuit in June alleging that the drugmaker provided free nursing services to persuade doctors to prescribe insulins Humalog and Humulin as well as osteoporosis drug Forteo. The suit noted that Eli Lilly worked with Healthstar Communications and VMS Biomarketing to provide thoseÃÂ ...
TheFix.com
November 16, 2017
Politico points out that prices for the company's best-selling insulin drug more than tripled while Azar led the company's U.S. division. This past May, prices for two of Lilly's insulin products, Humalog and Humulin, increased again by nearly 8%, the New York Times notes. Senate Democrats say they plan toÃÂ ...
FiercePharma
November 16, 2017
The lawsuit, filed in June and unsealed late last month, alleges Eli Lilly worked with Healthstar Communications and VMS Biomarketing to provide free nursing services to induce doctors to prescribe Lilly diabetes meds Humalog and Humulin, plus osteoporosis drug Forteo. The lawsuit also targets ...
Politico
November 14, 2017
One of Eli Lilly's insulins, Humulin R U-500, rose 325 percent in price from 2010 to 2015. Cummings tweeted that picking Azar is “like a fox guarding the hen house,” and a “slap in the face,” to Americans waiting for action on lower drug prices. “I have often said that the pharmaceutical industry owns ...
New York Times
November 13, 2017
If he is confirmed by the Senate, Mr. Azar would be returning to a sprawling agency where he served as general counsel and deputy secretary before spending a decade in the pharmaceutical industry. He resigned from Eli Lilly, which makes Cialis, Humulin and Trulicity among other popular and profitable ...
DailyCommerceNews
November 9, 2017
2017 Global Diabetes World Drug Market: Janumet, Victoza and Humulin. Global Diabetes World Drug Market: This market research report focuses on Past-Current Size, Shares, trends & Forecast to 2022. By Daniel Cruz -. November 9, 2017. 0. 23. Share on Facebook · Tweet on Twitter. Global Diabetes World Drug Market ...
Seeking Alpha
October 24, 2017
Key Product Sales: Humalog: $696.2M (+9%); Cialis: $564.9M (-4%); Alimta: $514.5M (-10%); Forteo: $441.7M (+13%); Humulin: $300.5MÂ ...
FiercePharma
October 23, 2017
It said the project will help it meet demand for Humalog, Humulin and other insulins, and put in place new technology for pipeline projects.
Market Realist
October 13, 2017
In 1H17, Humulin reported revenues of around $672.3 million, compared with $688.7 million in 1H16. In 2Q17, Humulin generated revenues of ...
Pharmacy Times
October 13, 2017
These concentrated insulins are available in the pen formulation, apart from Humulin R U-500, which is also available in the vial formulation ...
Market Realist
October 2, 2017
Humulin, the concentrated insulin products portfolio for controlling blood sugar levels in people with diabetes mellitus, reported an 8.0% rise in ...
The Republic
September 2, 2017
Other Lilly insulins saw hefty price increases, too, including Humulin, on the market since 1982. It has seen price increases totaling nearly 800 percent over the last two decades. The soaring prices at Indianapolis-based Lilly — and two other insulin makers, whose prices are climbing at similar rates — areÃÂ ...
Market Realist
July 28, 2017
Eli Lilly and Company's (LLY) Human Pharmaceuticals segment reported a rise of ~11.0% to ~$5.0 billion for 2Q17 compared to ~$4.6 billion ...
Pharmacy Times
July 24, 2017
Humulin U-500: Counseling Your Patients ... Humulin R U-500 from vials should only be administered using U-500 syringes and patients ...
CNBC
May 10, 2017
The increases, taken on May 2, were for drugs including the blood thinner Effient (9.9 percent), the psoriasis drug Taltz (6.9 percent) and the insulins Humalog and Humulin (7.8 percent). The increases fit a pattern at Lilly and many other drugmakers of single-digit percentage hikes once or twice a year,ÃÂ ...
Market Realist
December 31, 1999
In 3Q17, Humulin generated revenues of $300.5 million, a ~7% decline on a YoY basis and a 16% decline on a quarter-over-quarter basis. In 3Q17, in the US and international markets, Humulin generated revenues of $203.0 million and $97.5 million, respectively, compared to $195.6 million and $126.4ÃÂ ...
Indianapolis Business Journal
December 31, 1999
The Lilly drugs in question were insulins Humalog and Humulin, and osteoporosis drug Forteo. Those three medicines are among Lilly's top-selling products, accounting for a combined $5.6 billion in sales last year, or about 27 percent of Lilly's revenues. The behavior amounted to kickbacks and violated ...
BioPharma Dive
December 31, 1999
... capacity at one of its Indianapolis facilities, a move aimed at better meeting demand for diabetes treatments like Humalog and Humulin.
Caixin Global
December 31, 1999
Eli Lilly and Co.'s drop in third-quarter revenue from sales of the insulin drug Humulin outside the U.S. was "primarily due to buying patterns in ...
The Republic
September 2, 2017
Other Lilly insulins saw hefty price increases, too, including Humulin, on the market since 1982. It has seen price increases totaling nearly 800ÃÂ ...
Market Realist
August 31, 2017
The Humulin portfolio includes concentrated insulin products that are used to lower blood sugar levels in patients with diabetes mellitus.
American Council on Science and Health
August 29, 2017
A GMO insulin product was ready and Eli Lilly & Co. submitted NDA 18-790 for Biosynthetic Human Insulin (BHI) - Humulin. Though many FDAÃÂ ...
Market Realist
July 28, 2017
Eli Lilly and Company's (LLY) Human Pharmaceuticals segment reported a rise of ~11.0% to ~$5.0 billion for 2Q17 compared to ~$4.6 billionÃÂ ...
Pharmacy Times
July 24, 2017
Pharmacists looking to counsel patients on Humulin R U-500 can use counseling points that are very similar to U-100, which patients often findÃÂ ...
CNBC
May 10, 2017
... including the blood thinner Effient (9.9 percent), the psoriasis drug Taltz (6.9 percent) and the insulins Humalog and Humulin (7.8 percent).
Monthly Prescribing Reference (registration)
November 8, 2016
BD announced the launch of the BD U-500 Insulin Syringe, the first insulin syringe designed for patients with diabetes taking Humulin R U-500ÃÂ ...
Monthly Prescribing Reference (registration)
April 29, 2016
Eli Lilly announced the launch of Humulin R U-500 KwikPen (insulin human injection), a prefilled device containing a highly concentratedÃÂ ...
Diabetes In Control
January 22, 2016
For the first time Humulin % U-500 will now be available in a pen. This will help to prevent all the errors that this insulin has had in the pastÃÂ ...
Medgadget (blog)
March 23, 2017
Peptide Hormonesinclude drugs such as Humatrope and Serostim, which are harvested human growth hormone, other peptide hormone drugs include Humulin (human insulin) and Follicle-stimulating hormone (FSH). There has been a rise in the range ofÃÂ ...
BioPharma Dive
March 20, 2017
The Indianapolis-based company touted its efforts to keep prices low for patients, including a partnership with Express Scripts announced in December that aims to provide discounts for insulin drugs such as Lilly's Humalog, Humulin and Basaglar.
WhaTech
March 10, 2017
Human insulin drugs market has been further divided on the basis of drug type (rapid-acting, intermediate-acting, long-acting, short-acting, and premixed) and drug brands (Lantus, NovoRapid/Novolog, Humalog, Humulin, Insuman, Actrapid, Insulatard,ÃÂ ...
NetDugout
February 27, 2017
The branded diabetes pen available in U.S. like SymlinPen 60 & 120, Apidra SoloStar, Byetta, Humalog KwikPen, HumaPen LUXURA HD, Victoza, Humulin Pen, Lantus Solostar, Levemir FlexPen etc. is expected to show lucrative growth in U.S. over theÃÂ ...
Medgadget (blog)
February 23, 2017
Humulin by Lilly LLC, and Novolin and Velosulin by Novo Nordisk, are the major brands in the market. Various off label drugs are also prescribed to suppress the symptoms of insulin resistance.
|
news and opinion
|
